Your browser is no longer supported. Please, upgrade your browser.
Settings
AXDX [NASD]
Accelerate Diagnostics, Inc.
Index- P/E- EPS (ttm)-1.42 Insider Own3.60% Shs Outstand58.52M Perf Week10.33%
Market Cap542.80M Forward P/E- EPS next Y-1.20 Insider Trans-3.84% Shs Float33.28M Perf Month33.33%
Income-81.10M PEG- EPS next Q-0.33 Inst Own41.60% Short Float24.74% Perf Quarter-4.22%
Sales11.30M P/S48.04 EPS this Y9.70% Inst Trans-11.23% Short Ratio41.32 Perf Half Y25.76%
Book/sh-1.13 P/B- EPS next Y17.80% ROA-80.10% Target Price13.00 Perf Year-2.99%
Cash/sh1.12 P/C8.14 EPS next 5Y30.00% ROE150.40% 52W Range6.59 - 19.11 Perf YTD19.79%
Dividend- P/FCF- EPS past 5Y-6.70% ROI-76.10% 52W High-53.53% Beta1.95
Dividend %- Quick Ratio9.80 Sales past 5Y137.70% Gross Margin37.90% 52W Low34.65% ATR0.39
Employees224 Current Ratio11.10 Sales Q/Q8.70% Oper. Margin- RSI (14)68.70 Volatility4.19% 4.87%
OptionableYes Debt/Eq- EPS Q/Q-6.60% Profit Margin- Rel Volume0.58 Prev Close9.08
ShortableYes LT Debt/Eq- EarningsMay 06 AMC Payout- Avg Volume199.31K Price8.88
Recom2.40 SMA2015.32% SMA5013.68% SMA200-4.45% Volume103,140 Change-2.20%
Oct-08-20Initiated BTIG Research Neutral
Aug-07-20Upgrade Craig Hallum Hold → Buy $20
Sep-27-19Downgrade JP Morgan Neutral → Underweight $16
Nov-07-18Downgrade JP Morgan Overweight → Neutral
May-24-18Initiated Craig Hallum Hold $25
Dec-13-17Downgrade BTIG Research Buy → Neutral
Jul-12-17Resumed BTIG Research Buy $34
Mar-24-16Initiated JP Morgan Overweight $17
Dec-16-15Initiated Piper Jaffray Overweight
May-19-21 08:00AM  
May-17-21 02:18AM  
May-06-21 07:05PM  
04:05PM  
May-05-21 02:34PM  
Apr-29-21 05:03PM  
Apr-01-21 06:22AM  
Feb-28-21 01:02AM  
Feb-23-21 02:30PM  
Feb-06-21 01:25AM  
Feb-01-21 08:00AM  
08:00AM  
Jan-29-21 10:14AM  
Jan-28-21 06:17PM  
Jan-12-21 06:00AM  
Dec-14-20 07:07AM  
Nov-07-20 07:53AM  
Nov-05-20 04:29PM  
02:45PM  
Oct-29-20 12:35PM  
Oct-15-20 06:38AM  
Oct-12-20 09:05AM  
Sep-16-20 09:00AM  
Sep-10-20 09:00AM  
Aug-24-20 09:15AM  
Aug-19-20 10:30AM  
07:32AM  
03:58AM  
Aug-18-20 04:15PM  
Jul-30-20 12:33PM  
Jul-17-20 07:00AM  
Jul-16-20 08:00AM  
Jun-25-20 06:26PM  
Jun-15-20 09:20AM  
May-29-20 12:00PM  
May-26-20 08:51AM  
May-21-20 04:06PM  
May-09-20 10:00PM  
May-07-20 04:01PM  
Apr-30-20 12:34PM  
Apr-28-20 08:00AM  
Apr-22-20 12:00PM  
Apr-16-20 05:26PM  
08:09AM  
Apr-15-20 05:08PM  
05:07PM  
Apr-01-20 03:30PM  
Mar-07-20 12:26AM  
Feb-29-20 07:38AM  
Feb-20-20 12:31PM  
Feb-18-20 01:48PM  
Feb-11-20 12:30PM  
Jan-13-20 01:00AM  
Jan-03-20 04:01PM  
Dec-24-19 01:08PM  
Dec-08-19 03:00PM  
Dec-04-19 11:11AM  
07:00AM  
Dec-02-19 10:08AM  
08:00AM  
Nov-25-19 09:08PM  
Nov-18-19 10:04AM  
Nov-08-19 04:30PM  
Nov-07-19 06:25PM  
04:01PM  
Nov-04-19 07:45AM  
Oct-31-19 10:34AM  
Oct-28-19 06:15PM  
Oct-17-19 08:00AM  
Oct-03-19 08:00AM  
Sep-19-19 08:00AM  
Sep-18-19 10:20AM  
07:30AM  
Aug-14-19 09:00PM  
Aug-12-19 12:48PM  
Aug-09-19 02:24AM  
Aug-08-19 06:05PM  
04:06PM  
04:01PM  
Aug-05-19 12:18PM  
Aug-01-19 10:33AM  
Jul-15-19 02:15PM  
Jul-08-19 08:30AM  
Jun-19-19 03:41PM  
May-24-19 12:45PM  
May-22-19 12:56PM  
10:42AM  
May-10-19 01:23PM  
May-09-19 06:05PM  
05:01PM  
04:01PM  
May-08-19 04:05PM  
May-02-19 10:32AM  
Apr-26-19 11:44AM  
Apr-16-19 12:09PM  
Apr-05-19 07:22PM  
Mar-08-19 03:38PM  
Mar-01-19 07:48AM  
Feb-26-19 08:25AM  
Feb-21-19 07:28AM  
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REICHLING STEVENChief Financial OfficerMay 13Sale6.768,30356,12834,672May 14 04:23 PM
Price RonHead of Commercial OperationsMay 13Sale6.766,28242,46614,927May 14 04:22 PM
Phillips JackChief Executive OfficerMay 13Sale6.7625,064169,43374,017May 14 04:21 PM
Phillips JackChief Executive OfficerFeb 02Sale10.903,31336,11210,508Feb 03 04:50 PM
Phillips JackChief Executive OfficerFeb 01Option Exercise0.0010,000013,821Feb 03 04:50 PM
SCHULER JACK WDirectorJan 29Buy10.1830,868314,2361,107,891Feb 02 01:06 PM
REICHLING STEVENChief Financial OfficerJan 27Option Exercise2.9825,00074,50038,300Jan 27 05:17 PM
REICHLING STEVENChief Financial OfficerJan 27Sale15.2525,000381,25013,300Jan 27 05:17 PM
REICHLING STEVENChief Financial OfficerJan 26Option Exercise2.9824,91074,23238,210Jan 27 05:17 PM
REICHLING STEVENChief Financial OfficerJan 26Sale12.5024,910311,37513,300Jan 27 05:17 PM
REICHLING STEVENChief Financial OfficerJan 25Option Exercise2.9820,76161,86834,061Jan 27 05:17 PM
REICHLING STEVENChief Financial OfficerJan 25Sale10.5520,761219,02913,300Jan 27 05:17 PM
REICHLING STEVENChief Financial OfficerDec 17Sale7.378596,33115,583Feb 03 04:52 PM
Price RonHead of Commercial OperationsDec 17Sale7.377275,3581,874Feb 03 04:51 PM
Phillips JackChief Executive OfficerDec 17Sale7.371,54211,3653,821Feb 03 04:49 PM
REICHLING STEVENChief Financial OfficerNov 09Option Exercise2.9839,329117,20052,629Nov 12 05:16 PM
REICHLING STEVENChief Financial OfficerNov 09Sale9.5039,329373,62613,300Nov 12 05:16 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 18Option Exercise5.933,00017,7903,000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 18Sale12.003,00036,0000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 17Option Exercise5.932,00011,8602,000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 17Sale11.752,00023,5000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 16Option Exercise5.934,00023,7204,000Jun 22 07:26 PM
HUMPHRIES ROMNEYChief Scientific OfficerJun 16Sale11.004,00044,0000Jun 22 07:26 PM